Daniel S. Kohane

Daniel S. Kohane

Auto-generated profile, based on publicly available information

Daniel S. Kohane

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Boston Children’s Hospital, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2011 in Nature Nanotechnology
Verified
Journal Article
Open access
PDF file
TDTal Dvir
Tal Dvir
BTBrian P. Timko
Brian P. Timko
MBMark D. Brigham
Mark D. Brigham
SNShreesh R. Naik
Shreesh R. Naik
SKSandeep S. Karajanagi
Sandeep S. Karajanagi
DKDaniel S. Kohane
Daniel S. Kohane
Engineered cardiac patches for treating damaged heart tissues after a heart attack are normally produced by seeding heart cells within three-dimensional porous biomaterial scaffolds1,2,3. These biomaterials, which are usually made of either biological polymers such as alginate4 or synthetic polymers such as poly(lactic acid) (PLA)5, help cells organize into functioning tissues, but poor conductivity of these materials limits the ability of the patch to contract strongly as a unit6. Here, we show that incorporating gold nanowires within alginate scaffolds can bridge the electrically resistant pore walls of alginate and improve electrical communication between adjacent cardiac cells. Tissues grown on these composite matrices were thicker and better aligned than those grown on pristine alginate and when electrically stimulated, the cells in these tissues contracted synchronously. Furthermore, higher levels of the proteins involved in muscle contraction and electrical coupling are detected in the composite matrices. It is expected that the integration of conducting nanowires within three-dimensional scaffolds may improve the therapeutic value of current cardiac patches.

26 August 2012 in Nature Materials
Verified
Journal Article
Closed access
PDF file
BTBozhi Tian
Bozhi Tian
JLJia Liu
Jia Liu
TDTal Dvir
Tal Dvir
LJLihua Jin
Lihua Jin
JTJonathan H. Tsui
Jonathan H. Tsui
CLCharles Lieber
Charles Lieber

3 September 2010 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
BTBrian P. Timko
Brian P. Timko
TDTal Dvir
Tal Dvir
DKDaniel S. Kohane
Daniel S. Kohane

1 October 2008 in Biomaterials
Verified
Journal Article
Closed access
SHSarah P. Hudson
Sarah P. Hudson
RPRobert F. Padera
Robert F. Padera
RLRobert Langer
Robert Langer
DKDaniel S. Kohane
Daniel S. Kohane

16 March 2012 in Journal of the American Chemical Society
Verified
Journal Article
Open access
RTRong Tong
Rong Tong
HHHouman D. Hemmati
Houman D. Hemmati
RLRobert Langer
Robert Langer
DKDaniel S. Kohane
Daniel S. Kohane
We report a novel nanoparticulate drug delivery system that undergoes reversible volume change from 150 to 40 nm upon phototriggering with UV light. The volume change of these monodisperse nanoparticles comprising spiropyran, which undergoes reversible photoisomerization, and PEGylated lipid enables repetitive dosing from a single administration and enhances tissue penetration. The photoswitching allows particles to fluoresce and release drugs inside cells when illuminated with UV light. The mechanism of the light-induced size switching and triggered-release is studied. These particles provide spatiotemporal control of drug release and enhanced tissue penetration, useful properties in many disease states including cancer.

8 September 2009 in Nano Letters
Verified
Journal Article
Closed access
THTodd Hoare
Todd Hoare
JSJesus Santamaria
Jesus Santamaria
Gerardo F. GoyaGerardo F. Goya
Gerardo F. Goya
Silvia IrustaSilvia Irusta
Silvia Irusta
DLDebora Lin
Debora Lin
DKDaniel S. Kohane
Daniel S. Kohane